ST
Stereotaxis, Inc.
STXS · AMEX
$1.27 +0.80% (+$0.01)
1M -12.50%
Market Cap $122.9M
P/E Ratio -
Div. Yield -
ROE 132.62%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
28 /100
Expensive P/B 7.03x
P/S 4.09x
EV/FFO N/A
Growth
34 /100
Stable Book val. growth 16.30%
Rev. growth 4.78%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 73.02%
Gross margin 55.57%
FCF margin 51.56%
Quality
7 /100
Poor ROA 40.16%
ROIC 74.49%
Asset turnover 0.54x
Debt
89 /100
Low Current ratio 1.42x
Debt/Equity 0.30x
Debt/Assets N/A
Stability
64 /100
Moderate EPS volatility 14.41%
Beta 1.42x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about STXS
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
David L. Fischel
Employees
131
Headquarters
St. Louis
Upcoming events
10 NOV
Earnings
Upcoming earnings report